Grasim Industries

Grasim Q3 net higher at Rs334 cr despite outgoes on acquisitions

31 Jan 2015

Grasim Q1 net profit down 20% at Rs487 crore

02 Aug 2014

Grasim Q1 net falls over 15% to Rs610 crore

03 Aug 2013

Grasim Q4 net up marginally at Rs818 crore

04 May 2013

Grasim Q2 net rises 33 per cent to Rs669 crore

24 Jan 2012

Grasim Q1-FY'12 net vaults 40 per cent to Rs314 crore

30 Jul 2011

Grasim forced to suspend staple fibre production at Nagda plant

02 Jun 2011

Grasim to acquire one-third stake in Domsjo Fabriker

03 May 2011

Himachal Pradesh High Court quashes eco clearance to Grasim's Harish Cement

14 Dec 2010

Cement prices to remain under pressure, feels Grasim

02 Aug 2010

View details about the software product Informachine News Trackers

Latest articles

Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

 Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

 Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

AI startup Reflection signs over $1 billion computing deal with Nebius

 AI startup Reflection signs over $1 billion computing deal with Nebius

Tata Power explores $450 million overseas loan for business operations

 Tata Power explores $450 million overseas loan for business operations

TCS wins technology contract for New York JFK Airport’s $19 billion terminal

 TCS wins technology contract for New York JFK Airport’s $19 billion terminal

South Korean firms unveil $195 billion investment in AI and advanced industries

 South Korean firms unveil $195 billion investment in AI and advanced industries

HCLTech wins $1.14 billion AI transformation deal with European client

 HCLTech wins $1.14 billion AI transformation deal with European client

Microsoft launches Frontier to help enterprises accelerate AI adoption

 Microsoft launches Frontier to help enterprises accelerate AI adoption

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs

 AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs